Decoy Therapeutics Inc. Cash, Period Increase (Decrease)
Decoy Therapeutics Inc. (DCOY) reported Cash, Period Increase (Decrease) of -$3.23 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-07.
Discontinued › Notes
us-gaap:CashPeriodIncreaseDecrease · last filed 2018-03-07
- Decoy Therapeutics Inc. cash, period increase (decrease) for the quarter ending 2017-12-31 was -$966.09K.
- Decoy Therapeutics Inc. cash, period increase (decrease) for the quarter ending 2017-09-30 was -$18.97M.
- Decoy Therapeutics Inc. cash, period increase (decrease) for the quarter ending 2017-06-30 was $18.06M.
- Decoy Therapeutics Inc. cash, period increase (decrease) for the quarter ending 2017-03-31 was -$1.34M.
- Decoy Therapeutics Inc. cash, period increase (decrease) for fiscal 2017 was -$3.23M.
- Decoy Therapeutics Inc. cash, period increase (decrease) for fiscal 2016 was -$44.27M, a 234.84% decline from fiscal 2015.
- Decoy Therapeutics Inc. cash, period increase (decrease) for fiscal 2015 was $32.83M.
| Period end | Cash, Period Increase (Decrease) 1 month | Cash, Period Increase (Decrease) 3 month | Cash, Period Increase (Decrease) 4 month | Cash, Period Increase (Decrease) 4 month as first filed | Cash, Period Increase (Decrease) 6 month | Cash, Period Increase (Decrease) 9 month | Cash, Period Increase (Decrease) 10 month | Cash, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$966.09K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$19.94M derived: sum of 2 quarters · filed 2018-03-07 | -$1.89M derived: sum of 3 quarters · filed 2018-03-07 | -$3.23M 10-K · filed 2018-03-07 | ||||
| 2017-09-30 | -$18.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$919.55K derived: sum of 2 quarters · filed 2017-11-06 | -$2.26M 10-Q · filed 2017-11-06 | -$7.68M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2017-06-30 | $18.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $16.71M 10-Q · filed 2017-08-02 | $11.30M derived: sum of 3 quarters · filed 2018-03-07 | $185.56K derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2017-03-31 | -$1.34M 10-Q · filed 2017-05-03 | -$6.76M derived: sum of 2 quarters · filed 2018-03-07 | -$17.87M derived: sum of 3 quarters · filed 2018-03-07 | -$32.93M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-12-31 | -$5.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$16.53M derived: sum of 2 quarters · filed 2018-03-07 | -$31.58M derived: sum of 3 quarters · filed 2018-03-07 | -$44.27M 10-K · filed 2018-03-07 | ||||
| 2016-09-30 | -$11.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$26.17M derived: sum of 2 quarters · filed 2017-11-06 | -$38.86M 10-Q · filed 2017-11-06 | -$61.33M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-06-30 | -$15.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$27.75M 10-Q · filed 2017-08-02 | -$50.22M derived: sum of 3 quarters · filed 2018-03-07 | -$67.07M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2016-03-31 | -$12.69M 10-Q · filed 2017-05-03 | -$35.16M derived: sum of 2 quarters · filed 2018-03-07 | -$52.01M derived: sum of 3 quarters · filed 2018-03-07 | -$56.52M derived: sum of 4 quarters · filed 2018-03-07 | ||||
| 2015-12-31 | -$22.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$39.32M derived: sum of 2 quarters · filed 2018-03-07 | -$43.84M derived: sum of 3 quarters · filed 2018-03-07 | $32.83M 10-K · filed 2018-03-07 | ||||
| 2015-09-30 | -$16.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$21.36M derived: sum of 2 quarters · filed 2016-11-02 | $55.31M 10-Q · filed 2016-11-02 | |||||
| 2015-06-30 | -$4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $72.16M 10-Q · filed 2016-08-03 | ||||||
| 2015-03-31 | $76.67M 10-Q · filed 2016-05-04 | |||||||
| 2014-12-31 | $33.85M 10-K · filed 2017-03-08 | |||||||
| 2014-06-30 | $36.29M 10-Q · filed 2015-11-04 | $14.29M 10-Q · filed 2015-08-05 | ||||||
| 2014-03-31 | $10.71M 10-Q · filed 2015-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |